Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Researchers seek to clone ’mad cow disease’ resistant cattle strain

09.01.2004


Scientists in the Virginia-Maryland Regional College of Veterinary Medicine (VMRCVM) at Virginia Tech are trying to clone cattle that are genetically incapable of developing "Mad Cow Disease."

As federal and state government officials grapple with strategies to limit the economic and health risks associated with the troublesome discovery of the nation’s first case of Bovine Spongiform Encephalopathy (BSE) – or "Mad Cow Disease"-- Will Eyestone, research associate professor in Large Animal Clinical Sciences, and Bill Huckle, associate professor of biomedical science, are conducting important research with the little understood molecules believed to cause the deadly brain-wasting disease.

Eyestone, a molecular reproductive biologist who was senior research scientist for PPL Therapeutics, the organization that cloned Dolly the sheep, now heads the VMRCVM’s transgenic animal research program.



Most people think of disease as being caused by infectious organisms like bacteria, viruses, rickettsia, protozoa or fungi, explains Eyestone. Those microorganisms reproduce themselves to cause disease in fairly conventional ways, either inside a cell or elsewhere in the body.

But prions behave very differently than these more common disease-causing organisms, explains Eyestone. Prions are actually a form of protein that naturally occur in all mammals, though scientists remain uncertain about the exact purpose they serve in advanced mammals like humans. Transmissible spongiform encephalopathies like BSE and new variant Creutzfeldt-Jacob Disease (vCJD), the human form of the disease, are believed to occur when the non-pathogenic prions that normally reside in mammalian nervous systems are converted into pathogenic forms.

Proteins, the building blocks of metabolic processes, are long chains of amino acids that fold in upon themselves in predictable patterns and shapes that result from the bio-electrical relationships that exist between individual molecules, according to Eyestone. Proteins normally "fold" in only one way. But when the "normal" prions are infected by pathogenic prions, they begin to "fold" in another way that leads to disease.

In the case of BSE and vCJD, pathogenic prions introduced from contaminated food sources interact with normal prions in the body and transform them into the lethal agents that eventually create the "Swiss cheese-like" lesions in the brain that cause the devastating neurological symptoms of the disease.

The pathogenic prions that are ingested by cattle in contaminated feed do not seem to be affected by the normal enzymatic activity of the digestion process, explains Eyestone. The prions pass through the wall of the gut and are subsequently absorbed by innervated lymphatic tissues, where they eventually accumulate in the nerves, and then migrate to the spinal cord and brain. The process takes years, Eyestone says, which accounts for the five to seven year incubation period that characterizes both the animal and human forms of the disorder.

While scientists don’t know how to stop the pathogenic process once it gets underway, some, like Eyestone and Huckle, are interested in creating an animal that lacks the genomic architecture to code for the production of normal prions.

"In order to be susceptible to prion disease, the individual has to be able to express the prion," says Eyestone, who is using the same somatic cell transfer technology to clone a cow without normal prions that PPL used to create Dolly the sheep and Mr. Jefferson, the first cloned calf.

Basically, the process involves taking somatic cells harvested from an animal, and replacing the nucleus of that cell with the nucleus of another cell that possesses the desired genetic characteristics, and then implanting that embryo into the animal for a normal gestational development period.

"We know that if you knock out these prion proteins in laboratory mice that there is no apparent negative effect," said Eyestone. "We know that this prion does not appear to be required for normal functions of life. But the mouse has not been that informative to us and we are hoping that the cow will be more so."

The research is funded by the National Institutes of Health. The core objective of the NIH grant is to produce a cow that is genetically incapable of producing prions, and then determine whether or not the viability and function of the animal has been affected by the lack of the prion. Once the cow is cloned in late 2004, the researchers will conduct a number of behavioral and physiological evaluations of the animal.

If efforts to produce a normally functioning cow that lacks the genetic ability to code for the production of prions are successful, the researchers may have identified a strategy for finally containing the risks of this ominous disease.

While the prospects of "cloning" prion free cattle on the scale of America’s 100 million head cattle herd may seen daunting, Eyestone points out that with the widespread use of artificial insemination in modern agriculture, great strides could be made in as little as six or seven generations.

On a smaller scale, sub-populations of prion-free cattle could be produced for use in other tasks such as the production of pharmaceutical compounds that are eventually used in people, thereby eliminating the risk that a drug produced to promote human health and well-being might accidentally cause the deadly neurological condition.

Jeff Douglas | EurekAlert!
Further information:
http://www.technews.vt.edu/

More articles from Agricultural and Forestry Science:

nachricht Energy crop production on conservation lands may not boost greenhouse gases
13.03.2017 | Penn State

nachricht How nature creates forest diversity
07.03.2017 | International Institute for Applied Systems Analysis (IIASA)

All articles from Agricultural and Forestry Science >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A Challenging European Research Project to Develop New Tiny Microscopes

The Institute of Semiconductor Technology and the Institute of Physical and Theoretical Chemistry, both members of the Laboratory for Emerging Nanometrology (LENA), at Technische Universität Braunschweig are partners in a new European research project entitled ChipScope, which aims to develop a completely new and extremely small optical microscope capable of observing the interior of living cells in real time. A consortium of 7 partners from 5 countries will tackle this issue with very ambitious objectives during a four-year research program.

To demonstrate the usefulness of this new scientific tool, at the end of the project the developed chip-sized microscope will be used to observe in real-time...

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Researchers shoot for success with simulations of laser pulse-material interactions

29.03.2017 | Materials Sciences

Igniting a solar flare in the corona with lower-atmosphere kindling

29.03.2017 | Physics and Astronomy

As sea level rises, much of Honolulu and Waikiki vulnerable to groundwater inundation

29.03.2017 | Earth Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>